Are electronic signatures legally enforceable?

Yes. Electronic signatures meet U.S. standards under the ESIGN Act (15 U.S.C. §7001) and UETA (adopted by most states) when intent, consent, attribution, and record retention requirements are satisfied.

Do I need a BAA for health data in a contract?

If the document involves protected health information, a Business Associate Agreement is required under HIPAA and must be in place to ensure covered entity obligations and permitted uses are documented.

When is a digital signature (PKI) required?

Use cryptographic digital signatures when 21 CFR Part 11 controls are mandated for FDA-regulated electronic records, or when non-repudiation assurances beyond audit trails are contractually required.

Are notarization or witnesses required for these contracts?

Most commercial contracts do not require notarization, but certain instruments or filings and some state recording statutes may require notarization or witnesses; verify state rules before execution.

How can I revoke or amend an executed agreement?

Amendments require written agreement by authorized parties following contract change control procedures. Revocation or rescission must follow termination clauses or mutual written consent to avoid breach claims.

What if names or dates are entered incorrectly?

Minor clerical errors can be corrected by signed amendment; significant mismatches in legal names or effective dates may impair enforceability and should be corrected with a corrective instrument signed by authorized signatories.

Electronic Signature
Templates
Miscellaneous
Pharmaceutical Business Document

Pharmaceutical Business Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Pharmaceutical Business Agreement

This Pharmaceutical Business Agreement (Agreement) is entered into as of Effective Date: by and between Company Name: and Vendor Name: .

Company Address Vendor Address

Recitals

WHEREAS, Company engages in the manufacture, distribution, or commercialization of pharmaceutical products subject to applicable pharmaceutical regulations, and requires services, supply, testing, or development support consistent with current good manufacturing practices (cGMP); and

WHEREAS, Vendor represents that it has the expertise, facilities, and regulatory compliance programs to perform the services and/or supply Products described in this Agreement and agrees to comply with applicable laws, regulations, and standards governing pharmaceutical products, including pharmacovigilance and product quality; and

WHEREAS, the parties desire to set forth the terms and conditions under which Vendor will provide such services and/or Products to Company.

Scope of Work

Detailed Description of Services and Deliverables

Payment Terms

Total Contract Value:

Payment Schedule and Milestones

Invoicing Terms: Invoices shall be issued to the Company upon completion of the invoiced milestone or monthly as specified above. Payment due within days of receipt of a properly documented invoice.

Late Payment Fee: Unpaid amounts shall accrue interest at per month or the maximum lawful rate, whichever is lower, plus reasonable collection costs.

Invoice Remittance Address

Term and Termination

Term Commencement Date: — Term Expiration Date:

Either party may terminate this Agreement for convenience upon days' prior written notice to the other party. Either party may terminate for cause if the other party materially breaches any obligation and fails to cure such breach within days following written notice specifying the breach.

Termination for regulatory reasons: Company may suspend or terminate activities immediately upon written notice if continued performance would reasonably be expected to violate applicable pharmaceutical laws, or would place patient safety at risk.

Confidentiality

Each party shall treat as Confidential Information all nonpublic technical, regulatory, clinical, commercial or business information disclosed by the other party in connection with this Agreement. Confidential Information shall not be disclosed to third parties except to employees, contractors or professional advisors who have a need to know and are bound by confidentiality obligations no less protective than those set forth herein. Confidentiality obligations remain in force for years after termination, except that trade secrets shall remain protected for so long as they qualify as trade secret under applicable law. Upon termination or at Company request, Vendor shall promptly return or certify destruction of Confidential Information.

Regulatory Compliance, Safety and Quality

Vendor warrants that products and services supplied under this Agreement shall comply with all applicable laws, regulations and industry standards, including cGMP where applicable. Vendor shall maintain records necessary for regulatory inspection and shall notify Company promptly of any adverse events, product complaints, or potential recall conditions. Vendor shall cooperate in any recall, field correction, or regulatory action and shall bear costs attributable to Vendor's nonconformance.

Representations, Indemnification and Insurance

Each party represents that it has the authority to enter into this Agreement. Vendor shall indemnify, defend and hold Company harmless from any third-party claims arising from Vendor's negligence, willful misconduct, breach of warranties, or failure to comply with applicable pharmaceutical regulations, subject to limits of liability agreed by the parties.

Minimum Insurance Coverage (describe types and limits)

Audit Rights and Records

Company shall have the right, upon reasonable prior notice and during normal business hours, to audit Vendor's facilities, quality systems, and records relating to the services or Products provided under this Agreement, to confirm compliance with contractual and regulatory obligations. Vendor shall retain records for a period of years or as required by law.

Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to its conflict of laws principles.

Entire Agreement

This Agreement, including any Annexes or Statements of Work executed hereunder, constitutes the entire agreement between the parties with respect to the subject matter and supersedes all prior and contemporaneous agreements, proposals, or understandings, whether written or oral. No amendment shall be effective unless executed in writing by authorized representatives of both parties.

Notices

Company Notice Address Vendor Notice Address

Additional Provisions

Change Control: Any change to specifications, release criteria, or regulatory filings that may affect product quality, safety, or regulatory status shall require prior written approval by Company and such changes shall be documented in a formal change control process.

Remedies: Remedies provided in this Agreement are cumulative and in addition to any rights and remedies available at law or in equity, including injunctive relief for breach of confidentiality or misuse of Company intellectual property.

Company Representative:

By:

Date:

Vendor Representative:

By:

Date:

What the Pharmaceutical Business Document Is and Why It Matters

A Pharmaceutical Business Document is a formal written agreement or record used by life sciences organizations to govern commercial activities such as vendor supply, distribution, research collaborations, manufacturing agreements, and regulatory submissions. These documents capture commercial terms, product specifications, quality requirements, delivery schedules, intellectual property allocations, confidentiality obligations, and compliance commitments tied to FDA, HIPAA, and other regulatory frameworks. Properly drafted documents reduce operational risk, clarify responsibilities, and support auditability for regulators and business partners while serving as the authoritative record of each transaction.

Why a Clear Pharmaceutical Business Document Adds Value

A well-structured document limits regulatory exposure, preserves commercial rights, and streamlines audits and inspections. It makes roles, timelines, and quality expectations explicit to reduce disputes and support regulatory traceability without changing clinical or manufacturing practices.

Who Prepares and Who Signs These Documents

Typical creators include in-house legal teams, contract managers, procurement, regulatory affairs, and project leads who coordinate technical and commercial inputs.

Signers are usually authorized officers, procurement directors, or delegated signatories whose authority should be documented in corporate delegation records.

Common Roles and Responsibilities

Contract Manager

Manages the drafting, redline negotiations, version control, and renewal schedule for commercial and supply agreements. Ensures obligations are executable and coordinates signature routing across procurement, QA, and legal before final execution.

Chief Compliance Officer

Owns regulatory mapping to contract clauses (FDA, HIPAA, export controls), approves data-sharing and privacy terms, and maintains records required for inspections and regulatory submissions.

Core Elements Every Pharmaceutical Business Document Should Include

Ensure the document combines commercial clarity with regulatory and quality controls so it is enforceable and auditable across stakeholders and inspections.

Parties

Full legal names, entity types, and corporate addresses for every contracting party; include DUNS or tax ID where required for invoicing or compliance.

Scope

Clear description of goods, services, specifications, lot release procedures, and acceptance criteria linked to quality agreements and SOP references.

Payment Terms

Price, currency, invoice schedule, taxes, and consequences for late payment including interest or suspension of deliveries where applicable.

Quality & Regulatory

GMP expectations, release testing obligations, change control, audit rights, and notification procedures for product complaints or recalls.

IP & Data

Ownership or license grants for background and foreground IP, data use restrictions, and terms for clinical data sharing and publication.

Termination & Liability

Termination triggers, liquidated damages, limitation of liability, indemnities, and insurance minimums tailored to pharmaceutical risk profiles.

Stepwise Process to Complete and Execute the Document

Follow these sequential steps to prepare, review, and finalize the document while maintaining version control and auditability.

01

Draft: Assemble terms and supporting exhibits.
02

Review: Legal, QA, regulatory, and finance approvals.
03

Redline: Negotiate changes and track versions.
04

Sign: Execute via authorized signatories and preserve audit trail.

How to Configure a Digital Signing Workflow

Configure routing and authentication to match your approval hierarchy, security needs, and regulatory requirements for auditability.

Field	Configuration
Signing Order	Sequential or parallel, set per contract type
Authentication	Email link, SMS code, or advanced verifier
Attachment Rules	Require exhibits before completion
Retention Policy	Set automatic archive and export settings

Where to Send or File Completed Pharmaceutical Documents

Route final executed copies to stakeholders and secure repositories so obligations, audit trails, and regulatory records are preserved.

Legal Repository: Company contract repository with version control
Quality System: Attach to QMS under the related change control
Finance: Send final to accounts payable for invoicing
Regulatory Affairs: Store copies for inspection and submissions

Technical Requirements for Digital Execution and Storage

Choose a platform that meets encryption, audit trail, and export requirements for regulated records.

File formats: PDF, DOCX, and exportable XML
Integrations: Connectors for NetSuite, Salesforce, and Google Workspace
Security: TLS 1.2/1.3 and AES-256 encryption

Ensure the platform supports regulatory certifications you need (HIPAA BAA, 21 CFR Part 11 controls, SOC 2 Type II) and provides an immutable audit trail for executed documents.

Essential Security and Compliance Facts

Encryption: TLS 1.2/1.3; AES-256

Audit Trail: Timestamped action log

HIPAA: BAA required

21 CFR Part 11: Supported controls

SOC 2: Type II available

Access Control: SSO and MFA options

Common Pitfalls When Preparing Pharmaceutical Documents

Using vague deliverable descriptions that leave acceptance criteria undefined and invite performance disputes or shipment rejections.
Failing to align quality clauses to the actual manufacturing site’s capabilities, causing nonconforming lot rejections and delayed releases.
Not documenting signatory authority or delegation, which can lead counterparties to challenge the contract’s validity during disputes.
Ignoring data privacy and HIPAA rules when contracts involve patient or clinical trial data, creating regulatory and civil exposure.

Consequences of Incorrect or Incomplete Documents

Regulatory Warning: FDA inspection actions

Financial Loss: Damages and lost revenue

Contract Voidance: Disputed enforceability

Data Breach: HIPAA civil penalties

Supply Disruption: Manufacturing delays

Audit Failure: Failed compliance review

Typical Timelines and Critical Dates to Track

Track effective dates, delivery schedules, quality hold periods, renewal windows, and notice deadlines to avoid missed obligations.

Effective Date and Term:

Start date in MM/DD/YYYY; drives renewals

Delivery Schedule:

Milestones for shipments and acceptance

Quality Hold Period:

Time for testing before release

Renewal Notice:

Window to provide nonrenewal notice

Termination Notice:

Period required to terminate for convenience

Pricing and Feature Comparison for eSignature Vendors (signNow First)

Compare baseline pricing and core feature availability across vendors; vendor columns list starting price and select feature flags without billing date references.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No envelope cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently Asked Questions About Pharmaceutical Business Documents

These answers address common legal, technical, and procedural questions encountered when preparing and executing regulated business documents.

Need help? Contact support

Are electronic signatures legally enforceable?
Yes. Electronic signatures meet U.S. standards under the ESIGN Act (15 U.S.C. §7001) and UETA (adopted by most states) when intent, consent, attribution, and record retention requirements are satisfied.
Do I need a BAA for health data in a contract?
If the document involves protected health information, a Business Associate Agreement is required under HIPAA and must be in place to ensure covered entity obligations and permitted uses are documented.
When is a digital signature (PKI) required?
Use cryptographic digital signatures when 21 CFR Part 11 controls are mandated for FDA-regulated electronic records, or when non-repudiation assurances beyond audit trails are contractually required.
Are notarization or witnesses required for these contracts?
Most commercial contracts do not require notarization, but certain instruments or filings and some state recording statutes may require notarization or witnesses; verify state rules before execution.
How can I revoke or amend an executed agreement?
Amendments require written agreement by authorized parties following contract change control procedures. Revocation or rescission must follow termination clauses or mutual written consent to avoid breach claims.
What if names or dates are entered incorrectly?
Minor clerical errors can be corrected by signed amendment; significant mismatches in legal names or effective dates may impair enforceability and should be corrected with a corrective instrument signed by authorized signatories.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now